Basal Plus GLP1-ra on Glycemic Variability in CKD

NCT05218915 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Diabetic Kidney Disease

Interventions

DRUG: Dulaglutide
DRUG: Insulin Degludec
DEVICE: Continuous glucose monitor

Sponsor

Elaine Chow